Comparison ofmicroneedling vs microneedling with platelet rich plasma in the treatment of male-pattern hairloss
Phase 4
- Conditions
- Health Condition 1: L649- Androgenic alopecia, unspecified
- Registration Number
- CTRI/2024/04/065133
- Lead Sponsor
- Government Medical College and Hospital, Chandigarh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Males above the age of 18 years diagnosed with AGA Hamilton grade 3, 4, 5
2. New cases of male pattern hair loss
3. Previously treated cases not under any treatment for past 6 months
Exclusion Criteria
1. Malignancy or chemotherapy
2. Hematological or autoimmune disorder
3. Thrombocyte dysfunction, bleeding disorders or on anticoagulant therapy
4. Scalp area to be treated having any infection or dermatitis
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the improvement in hair growthTimepoint: The three primary efficacy measures will be the change in total and <br/ ><br>terminal hair count, scoring of the global photographs by evaluators and patient self assessment, <br/ ><br>assessed in both the groups at baseline and at 4 weekly intervals at 4, 8 and 12 weeks.
- Secondary Outcome Measures
Name Time Method Adverse Effects of TreatmentTimepoint: At each follow up visits- 4, 8 & 12 weeks.